Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study

Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study

Leon Alexander Mclaren Berge,1– 3 Bettina Kulle Andreassen,1 Jo Steinson Stenehjem,1,2,4 Trond Heir,5,6 Øystein Karlstad,7 Asta Juzeniene,8 Reza Ghiasvand,1,9 Inger Kristin Larsen,10 Adele C Green,11,12 Marit Bragelien Veierød,2 Trude Eid Robsahm1,3 1Department of Res...

Full description

Bibliographic Details
Main Authors: Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Clinical Epidemiology
Subjects:
immunosuppressants
corticosteroids
melanoma
prescription drugs
pharmacoepidemiology
registry-based.
Online Access:https://www.dovepress.com/use-of-immunomodulating-drugs-and-risk-of-cutaneous-melanoma-a-nationw-peer-reviewed-article-CLEP

Internet

https://www.dovepress.com/use-of-immunomodulating-drugs-and-risk-of-cutaneous-melanoma-a-nationw-peer-reviewed-article-CLEP

Similar Items